2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Over the last 12 months, insiders at 2seventy bio, Inc. have bought $10.8M and sold $776,222 worth of 2seventy bio, Inc. stock.
On average, over the past 5 years, insiders at 2seventy bio, Inc. have bought $7.65M and sold $554,127 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Casdin Capital, LLC (director) — $12.31M. Kynam Capital Management, LP (10 percent owner) — $3.65M. Kynam Global Healthcare Master Fund, LP (10 percent owner) — $3.05M.
The last purchase of 40,000 shares for transaction amount of $203,992 was made by Casdin Capital, LLC (director) on 2024‑03‑26.
2024-06-03 | Sale | Eatwell Victoria | Chief Financial Officer | 1,167 0.0023% | $4.18 | $4,881 | -5.98% | |
2024-06-03 | Sale | Snow Jessica | See Remarks | 649 0.0013% | $4.18 | $2,714 | -5.98% | |
2024-05-03 | Sale | Snow Jessica | See Remarks | 15 <0.0001% | $4.91 | $74 | -9.68% | |
2024-03-26 | Casdin Capital, LLC | director | 40,000 0.0812% | $5.10 | $203,992 | -8.57% | ||
2024-03-25 | Casdin Capital, LLC | director | 330,000 0.6747% | $5.07 | $1.67M | -7.35% | ||
2024-03-22 | Casdin Capital, LLC | director | 147,377 0.2903% | $5.12 | $754,069 | -11.40% | ||
2024-03-21 | Casdin Capital, LLC | director | 300,000 0.5822% | $4.90 | $1.47M | -9.18% | ||
2024-01-05 | Sale | Leschly Nick | President and CEO | 1,554 0.003% | $3.75 | $5,833 | +19.69% | |
2024-01-05 | Sale | Gregory Philip D | Chief Scientific Officer | 795 0.0015% | $3.75 | $2,984 | +19.69% | |
2024-01-05 | Sale | Baird William D III | Chief Operating Officer | 1,380 0.0027% | $3.75 | $5,180 | +19.69% | |
2024-01-03 | Sale | Leschly Nick | President and CEO | 72,312 0.143% | $3.87 | $279,739 | +18.76% | |
2024-01-03 | Sale | Gregory Philip D | Chief Scientific Officer | 25,613 0.0506% | $3.87 | $99,084 | +18.76% | |
2024-01-03 | Sale | Baird William D III | Chief Operating Officer | 33,651 0.0665% | $3.87 | $130,179 | +18.76% | |
2023-08-22 | Sale | Leschly Nick | President and CEO | 9,312 0.0184% | $5.49 | $51,090 | -23.77% | |
2023-08-22 | Sale | Gregory Philip D | Chief Scientific Officer | 6,159 0.0122% | $5.49 | $33,791 | -23.77% | |
2023-08-22 | Sale | Baird William D III | Chief Financial Officer | 7,031 0.0139% | $5.49 | $38,576 | -23.77% | |
2023-08-10 | Kynam Global Healthcare Master Fund, LP | 10 percent owner | 515,414 1.0209% | $5.92 | $3.05M | -28.76% | ||
2023-08-10 | Kynam Capital Management, LP | 10 percent owner | 515,414 1.0209% | $5.92 | $3.05M | -28.76% | ||
2023-08-10 | Kynam Capital Management, LP | 10 percent owner | 100,000 0.1995% | $5.96 | $596,000 | -28.76% | ||
2023-08-03 | Sale | Leschly Nick | President and CEO | 9,060 0.018% | $6.13 | $55,499 | -30.49% |
Kynam Capital Management, LP | 10 percent owner | 5953825 11.7627% | $3.60 | 2 | 0 | |
Kynam Global Healthcare Master Fund, LP | 10 percent owner | 5953825 11.7627% | $3.60 | 1 | 0 | |
Casdin Capital, LLC | director | 2000000 3.8978% | $3.60 | 4 | 0 | |
Leschly Nick | President and CEO | 1085476 2.1445% | $3.60 | 1 | 10 | <0.0001% |
Gregory Philip D | Chief Scientific Officer | 230842 0.4561% | $3.60 | 0 | 9 | |
Baird William D III | Chief Operating Officer | 161335 0.3187% | $3.60 | 0 | 11 | |
Eatwell Victoria | Chief Financial Officer | 95480 0.1857% | $3.60 | 0 | 1 | |
Snow Jessica | See Remarks | 55622 0.1095% | $3.60 | 0 | 2 | |
Heffron Nicola | Chief Operating Officer | 89182 0.1762% | $3.60 | 0 | 8 |
Kynam Capital Management Lp | $31.85M | 11.58 | 5.95M | 0% | +$0 | 0.4 | |
Morgan Stanley | $23.31M | 8.48 | 4.36M | -10.02% | -$2.6M | <0.01 | |
Goldman Sachs | $22.59M | 8.21 | 4.22M | -6.37% | -$1.54M | <0.01 | |
BlackRock | $20.89M | 7.6 | 3.91M | -0.16% | -$33,806.65 | <0.0001 | |
The Vanguard Group | $19.96M | 7.26 | 3.73M | -6.38% | -$1.36M | <0.0001 | |
Baker Bros Advisors LP | $13.36M | 4.86 | 2.5M | 0% | +$0 | 0.17 | |
Madison Avenue Partners, LP | $13.02M | 4.73 | 2.43M | +38.66% | +$3.63M | 2.13 | |
Casdin Capital | $10.7M | 3.89 | 2M | +69.12% | +$4.37M | 0.8 | |
Healthcare Of Ontario Pension Plan Trust Fund | $9.29M | 3.38 | 1.74M | New | +$9.29M | 0.03 | |
Point72 Asset Management | $8.63M | 3.14 | 1.61M | +360.94% | +$6.76M | 0.02 | |
Engine Capital Management Lp | $7.99M | 2.91 | 1.49M | 0% | +$0 | 1.61 | |
DAFNA Capital Management, LLC | $6.44M | 2.34 | 1.2M | -16.82% | -$1.3M | 1.5 | |
Eversept Partners LP | $6.3M | 2.29 | 1.18M | +3.39% | +$206,333.44 | 0.47 | |
Geode Capital Management | $6.12M | 2.22 | 1.14M | +4.97% | +$289,820.96 | <0.01 | |
State Street | $5.35M | 1.95 | 1M | +2.35% | +$122,632.70 | <0.0001 | |
JPMorgan Chase | $5.16M | 1.88 | 963,712 | -4.96% | -$269,126.39 | <0.0001 | |
Cowen Group | $4.28M | 1.56 | 800,000 | 0% | +$0 | 0.14 | |
Millennium Management LLC | $3.61M | 1.31 | 675,433 | -71.08% | -$8.88M | <0.01 | |
Charles Schwab | $3.29M | 1.2 | 614,525 | -0.77% | -$25,626.50 | <0.01 | |
Bank of America | $2.84M | 1.03 | 530,063 | +211.72% | +$1.93M | <0.0001 | |
Marshall Wace | $2.37M | 0.86 | 443,615 | -60.03% | -$3.57M | <0.01 | |
Northern Trust | $2.27M | 0.83 | 424,656 | +1.35% | +$30,275.65 | <0.0001 | |
Jacobs Levy Equity Management | $2.03M | 0.74 | 379,586 | New | +$2.03M | 0.01 | |
Venator Management Llc | $1.74M | 0.63 | 325,000 | +85.71% | +$802,500.00 | 0.55 | |
Dimensional Fund Advisors | $1.23M | 0.45 | 229,216 | -6.68% | -$87,734.61 | <0.0001 | |
Wellington Management Company | $1.08M | 0.39 | 202,073 | -60.84% | -$1.68M | <0.0001 | |
BNY Mellon | $999,817.00 | 0.36 | 186,882 | -5.44% | -$57,501.70 | <0.0001 | |
AQR Capital | $909,003.00 | 0.33 | 169,907 | -47.53% | -$823,413.65 | <0.01 | |
Barclays | $892,000.00 | 0.32 | 166,722 | +99.54% | +$444,978.11 | <0.0001 | |
Mirae Asset Global Investments Co Ltd | $1.35M | 0.29 | 146,901 | +85.99% | +$625,533.89 | <0.01 | |
Susquehanna Fundamental Investments Llc | $739,600.00 | 0.27 | 138,243 | New | +$739,600.00 | 0.04 | |
Prudential Financial | $576,281.00 | 0.21 | 107,716 | -11.65% | -$75,970.05 | <0.01 | |
Invesco | $544,496.00 | 0.2 | 101,775 | +116.19% | +$292,634.17 | <0.0001 | |
Nuveen | $519,908.00 | 0.19 | 97,179 | 0% | +$0 | <0.0001 | |
Bridgeway Capital Management | $517,345.00 | 0.19 | 96,700 | 0% | +$0 | 0.01 | |
HighVista Strategies | $500,225.00 | 0.18 | 93,500 | New | +$500,225.00 | 0.18 | |
Fidelity Investments | $469,147.00 | 0.17 | 87,691 | +0.38% | +$1,765.50 | <0.0001 | |
Wedmont Private Capital | $483,808.00 | 0.17 | 85,934 | New | +$483,808.00 | 0.04 | |
RhumbLine Advisers | $436,878.00 | 0.16 | 81,662 | +2.03% | +$8,709.53 | <0.0001 | |
Exchange Traded Concepts, LLC | $384,949.00 | 0.14 | 71,953 | +107.86% | +$199,753.18 | 0.01 | |
American Century Investments | $366,957.00 | 0.13 | 68,590 | +51.27% | +$124,366.27 | <0.0001 | |
HSBC | $364,849.00 | 0.13 | 68,196 | -7.48% | -$29,499.93 | <0.0001 | |
State of Wisconsin Investment Board | $333,840.00 | 0.12 | 62,400 | New | +$333,840.00 | <0.01 | |
UBS | $285,497.00 | 0.1 | 53,364 | -24.72% | -$93,731.87 | <0.0001 | |
AllianceBernstein | $263,734.00 | 0.1 | 49,296 | -13.71% | -$41,890.56 | <0.0001 | |
Citadel Advisors LLC | $259,571.00 | 0.09 | 48,518 | -65.81% | -$499,534.27 | <0.0001 | |
Martingale Asset Management L P | $241,596.00 | 0.09 | 45,158 | New | +$241,596.00 | 0.01 | |
Balyasny Asset Management Llc | $205,622.00 | 0.08 | 38,434 | New | +$205,622.00 | <0.01 | |
Susquehanna International Group | $176,738.00 | 0.06 | 33,035 | -62.39% | -$293,159.84 | <0.0001 | |
T. Rowe Price | $155,000.00 | 0.06 | 28,929 | +11.11% | +$15,500.54 | <0.0001 |